Cognitive Impairment Associated with Schizophrenia: a Review of the Humanistic Burden

被引:56
|
作者
Kitchen, Helen [1 ]
Rofail, Diana
Heron, Louise
Sacco, Pat [2 ]
机构
[1] Adelphi Mill, Adelphi Values, Bollington SK10 5JB, Cheshire, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
关键词
burden; cognitive impairment associated with schizophrenia; conceptual model; cost; humanistic; patient reported outcome; schizophrenia; QUALITY-OF-LIFE; ANTIPSYCHOTIC MEDICATIONS; 2ND-GENERATION ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; ATYPICAL ANTIPSYCHOTICS; EXECUTIVE FUNCTION; NEGATIVE SYMPTOMS; ECONOMIC BURDEN; UNITED-STATES;
D O I
10.1007/s12325-012-0001-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (CIAS); (b) develop a conceptual model that depicts the signs and symptoms of CIAS along with key concepts important to patients; and (c) consider the adequacy of potential patient-reported outcome (PRO) instruments for assessing future treatments. Methods: The following electronic databases were searched for articles published between January 1999 and November 2009 related to CIAS and PROs, or cost of illness: Medline; Embase; PsycINFO; the Health Economic Evaluation Database; and the National Health Service Economic Evaluation Database and Health Technology Assessment databases at the Centre for Reviews and Dissemination, University of York. Results: The literature search revealed 3950 abstracts, of which 101 articles were reviewed in detail. Cognitive functions affected include memory, attention/concentration, problem solving, learning, executive function, processing speed, and social cognition. Cognitive impairment impacts the ability of individuals to carry out activities of daily living, work productively, function socially, and adhere to treatment. These effects have economic ramifications through increased direct and indirect costs associated with the treatment of schizophrenia. The literature revealed 39 PRO instruments that have been used to assess functioning. However, no single instrument captures all key concepts of importance to patients with schizophrenia. Conclusion: The significant burden from CIAS for patients and society has implications for designing future treatments and health strategies to improve functional outcomes.
引用
收藏
页码:148 / 162
页数:15
相关论文
共 50 条
  • [41] AN ASSESSMENT OF THE HUMANISTIC IMPACT OF SCHIZOPHRENIA IN RELATION TO CAREGIVER AND PRODUCTIVITY BURDEN
    Qureshi, Z.
    Samant, S.
    Shepherd, J.
    Bailey, H.
    Pike, J.
    Khandker, R.
    VALUE IN HEALTH, 2019, 22 : S237 - S237
  • [42] THE COST OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA
    SEVY, S
    DAVIDSON, M
    SCHIZOPHRENIA RESEARCH, 1995, 17 (01) : 1 - 3
  • [43] Characterisation of cognitive impairment in schizophrenia
    Sharma, T
    LANCET NEUROLOGY, 2003, 2 (01): : 10 - 10
  • [44] The treatment of cognitive impairment in schizophrenia
    Goff, Donald C.
    Hill, Michele
    Barch, Deanna
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (02) : 245 - 253
  • [45] Cognitive impairment in adolescents with schizophrenia
    Kenny, JT
    Friedman, L
    Findling, RL
    Swales, TP
    Strauss, ME
    Jesberger, JA
    Schulz, SC
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (11): : 1613 - 1615
  • [46] AGGRESSIVENESS AND COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA
    Dutczak, B.
    Bidzan, L.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [47] Management of schizophrenia with cognitive impairment
    Harvey, PD
    PSYCHIATRIC ANNALS, 2000, 30 (01) : 53 - +
  • [48] Timing of Cognitive Impairment in Schizophrenia
    Weiser, Mark
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 23 - 24
  • [49] COGNITIVE EXCEPTIONALITY AND IMPAIRMENT IN SCHIZOPHRENIA
    Ammari, Narmeen
    Heinrichs, Walter
    Hall, Geoffrey
    Miles, Ashley A.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S115 - S115
  • [50] VALUATION OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA
    Santi, I
    Lloyd, A.
    Hastedt, C.
    Versteegh, M.
    VALUE IN HEALTH, 2022, 25 (01) : S274 - S274